Fuji Pharma Co., Ltd.

¥1,778As of Sun 8 Nov 2026, 12:00 UTC
TSE:4554Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 5.71%
Div yield 2.76%
ROE 6.14%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.33
PE TTM 14.89
TSR TTM 15.38%
Mkt cap ¥46.44B
ROIC 8.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,289
28.72%
(39.34%)
Hold 6|8|8|8|4
1Q26
2Q26
3Q26
4Q26
Earnings per share¥
23.49
22.64
22.89
24.22
21.22%
10.86%
15.61%
10.92%
Revenue¥B
4.325
4.493
4.360
4.529
16.33%
16.95%
8.40%
10.32%
Peers (US$294.9M)
Cap (US$)
PE
365.3M
11.06x
Capital
TTM
5Y
10Y
Leveragex
0.786
0.390
0.350
EBIT/Intx
1.599
0.311
0.240
Own earn%
(54.82)
(211.17)
(169.92)
Sh yield%
33.67
46.13
46.23
Owners
Insiders/Inst%
9.55
61.17
Short interest%
0.71
SBC / revenue%
4.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
20–24
$1 testx
0.3
Incr. ROIC%
5